In The News: School of Integrated Health Sciences

MegaDoctor News

A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer’s disease.

News Medical

A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.

Todo Noticias

Neuroscientists show that chronic hyperglycemia affects fundamental aspects of memory.

Knowridge Science Report

In a new study from the University of Nevada, Las Vegas, researchers confirmed the link between type 2 diabetes and Alzheimer’s disease.

Pharmabiz

Eisai and Biogen announced that Eisai has initiated a rolling submission to the US Food and Drug Administration (FDA) of a Biologics License Application (BLA) for lecanemab (BAN2401), the company’s investigational anti-amyloid beta (Aß) protofibril antibody, for the treatment of early Alzheimer’s disease (early AD).

Being Patient

Optimistic about the drug’s efficacy, the company has initiated its submission for accelerated FDA approval.

ScienceDaily

A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.

Fantasy Mundo

A team of neuroscientists at UNLV has reinforced the evidence for a link between type II diabetes and Alzheimer's disease.

Health H24

A team of neuroscientists from the University of Nevada, Las Vegas-UNLV confirms the link between type II diabetes and Alzheimer's disease.

Medical Xpress

A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.

Mirage News

A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer’s disease.

KLAS-TV: 8 News Now

A new program at UNLV is addressing a critical healthcare shortage in the Las Vegas valley.